Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1986 1
1988 2
1996 2
2000 1
2006 2
2008 1
2009 3
2011 1
2012 2
2013 2
2014 2
2015 4
2016 3
2017 1
2018 3
2019 3
2020 4
2021 9
2022 4
2023 4
2024 3
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Single-cell genomic variation induced by mutational processes in cancer.
Funnell T, O'Flanagan CH, Williams MJ, McPherson A, McKinney S, Kabeer F, Lee H, Salehi S, Vázquez-García I, Shi H, Leventhal E, Masud T, Eirew P, Yap D, Zhang AW, Lim JLP, Wang B, Brimhall J, Biele J, Ting J, Au V, Van Vliet M, Liu YF, Beatty S, Lai D, Pham J, Grewal D, Abrams D, Havasov E, Leung S, Bojilova V, Moore RA, Rusk N, Uhlitz F, Ceglia N, Weiner AC, Zaikova E, Douglas JM, Zamarin D, Weigelt B, Kim SH, Da Cruz Paula A, Reis-Filho JS, Martin SD, Li Y, Xu H, de Algara TR, Lee SR, Llanos VC, Huntsman DG, McAlpine JN; IMAXT Consortium; Shah SP, Aparicio S. Funnell T, et al. Nature. 2022 Dec;612(7938):106-115. doi: 10.1038/s41586-022-05249-0. Epub 2022 Oct 26. Nature. 2022. PMID: 36289342 Free PMC article.
Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group.
Mendoza N, Ramírez I, de la Viuda E, Coronado P, Baquedano L, Llaneza P, Nieto V, Otero B, Sánchez-Méndez S, de Frutos VÁ, Andraca L, Barriga P, Benítez Z, Bombas T, Cancelo MJ, Cano A, Branco CC, Correa M, Doval JL, Fasero M, Fiol G, Garello NC, Genazzani AR, Gómez AI, Gómez MÁ, González S, Goulis DG, Guinot M, Hernández LR, Herrero S, Iglesias E, Jurado AR, Lete I, Lubián D, Martínez M, Nieto A, Nieto L, Palacios S, Pedreira M, Pérez-Campos E, Plá MJ, Presa J, Quereda F, Ribes M, Romero P, Roca B, Sánchez-Capilla A, Sánchez-Borrego R, Santaballa A, Santamaría A, Simoncini T, Tinahones F, Calaf J. Mendoza N, et al. Among authors: ribes m. Maturitas. 2022 Dec;166:65-85. doi: 10.1016/j.maturitas.2022.08.008. Epub 2022 Aug 30. Maturitas. 2022. PMID: 36081216
Clonal fitness inferred from time-series modelling of single-cell cancer genomes.
Salehi S, Kabeer F, Ceglia N, Andronescu M, Williams MJ, Campbell KR, Masud T, Wang B, Biele J, Brimhall J, Gee D, Lee H, Ting J, Zhang AW, Tran H, O'Flanagan C, Dorri F, Rusk N, de Algara TR, Lee SR, Cheng BYC, Eirew P, Kono T, Pham J, Grewal D, Lai D, Moore R, Mungall AJ, Marra MA; IMAXT Consortium; McPherson A, Bouchard-Côté A, Aparicio S, Shah SP. Salehi S, et al. Nature. 2021 Jul;595(7868):585-590. doi: 10.1038/s41586-021-03648-3. Epub 2021 Jun 23. Nature. 2021. PMID: 34163070 Free PMC article.
Ivermectin to Control Malaria - A Cluster-Randomized Trial.
Chaccour C, Maia M, Kariuki M, Ruiz-Castillo P, Wanjiku C, Kasiwa L, Brazeal A, Casellas A, Ngama M, Onyango T, Elobolobo E, Kazungu K, Mael M, Wangari W, Nuru K, Otuko R, Sanz A, Ringera I, Matano A, Mitora S, Ribes M, Brew J, Gorski N, Nicolas P, Stanulovic S, Omondi I, Furnival-Adams J, Túnez L, Mbarak J, Vegove V, Yaa E, Mramba S, Kibet Y, Nyambura N, Rotich C, Wanjiru S, Vura M, Wanjiku F, Sam L, Collins L, Xia K, Hammann F, Saúte F, Rudd M, Rist C, Jones C, Mwangangi J, Rabinovich NR. Chaccour C, et al. Among authors: ribes m. N Engl J Med. 2025 Jul 24;393(4):362-375. doi: 10.1056/NEJMoa2411262. N Engl J Med. 2025. PMID: 40700688 Clinical Trial.
Defining the noma research agenda.
Galli A, Comparet M, Dagne DA, Baratti-Mayer D, Cao TH, Guérin PJ, Guevara M, Hetzel MW, Jeantet C, Mpinga EK, Muendane V, Okanlawon M, Placella E, Ribes M, Sherlock M, Utzinger J, Steinmann P. Galli A, et al. Among authors: ribes m. PLoS Negl Trop Dis. 2025 Apr 21;19(4):e0012940. doi: 10.1371/journal.pntd.0012940. eCollection 2025 Apr. PLoS Negl Trop Dis. 2025. PMID: 40257975 Free PMC article.
Robust consensus nuclear and cell segmentation.
Irfan MO, González-Solares EA, Whitmarsh T, Molaeinezhad A, Al Sa'd M, Mulvey CM, Ribes MP, Fatemi A, Bressan D, Walton NA. Irfan MO, et al. Among authors: ribes mp. Front Genet. 2025 Jul 15;16:1547788. doi: 10.3389/fgene.2025.1547788. eCollection 2025. Front Genet. 2025. PMID: 40734708 Free PMC article.
Heterotrophy in marine animal forests in an era of climate change.
Denis V, Ferrier-Pagès C, Schubert N, Coppari M, Baker DM, Camp EF, Gori A, Grottoli AG, Houlbrèque F, Maier SR, Mancinelli G, Martinez S, Yalçın Özdilek Ş, Radice VZ, Ribes M, Richter C, Viladrich N, Rossi S. Denis V, et al. Among authors: ribes m. Biol Rev Camb Philos Soc. 2024 Jun;99(3):965-978. doi: 10.1111/brv.13053. Epub 2024 Jan 29. Biol Rev Camb Philos Soc. 2024. PMID: 38284299 Review.
66 results